Диссертация (1144820), страница 57
Текст из файла (страница 57)
Risk factors for pre-eclampsia at antenatalbooking: systematic review of controlled studies // BMJ. – 2005. – V. 330(7491). –P. 565.153.Dufour C., Casane D., Denton D., Wickings J., Corvol P., Jeunemaitre X.Human-chimpanzee DNA sequence variation in the four major genes of the reninangiotensin system // Genomics. – 2000. – V. 1;69(1). – P.
14–26.154.Durán-Reyes G., Gómez-Meléndez M., Moralí-de la Brena G., Mercado-Pichardo E., Medina-Navarro R., Hicks-Gómez J.J. Nitric oxide synthesisinhibition suppresses implantation and decreases cGMP concentration and proteinperoxidation // Life Sciences.
– 1999. – V. 21. – P. 2259–2268.376377155.Dzida G., Sobstyl J., Puzniak A., Golon P., Mosiewicz J., Hanzlik J.Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type1 genes in essential hypertension in a Polish population // Med. Sci. Monit. – 2001.– V. 7(6). – P. 1236–1241.156.Ehsanipoor R.M., Fortson W., Fitzmaurice L.E., Liao W.X., Wing D.A.,Chen D.B., Chan K.
Nitric oxide and carbon monoxide production and metabolismin preeclampsia // Reprod. Sci. – 2013. – V. 20, №5. – P. 542–548.157.Enquobahrie D.A., Qiu C., Muhie S.Y., Williams M.A. Maternalperipheral blood gene expression in early pregnancy and preeclampsia // Int. J.Mol. Epidemiol. Genet. – 2011. – V.
2, № 1. – P. 78–94.158.Esplin M.S., Fausett M.B., Fraser A., Kerber R., Mineau G., Carrillo J.,Varner M.W. Paternal and maternal components of the predisposition topreeclampsia // N. Engl. J. Med. – 2001. – V. 344. – P. 867–872.159.Favis R., Day J.P., Gerry N.P., Phelan C., Narod S., Barany F. UniversalDNA array detection of small insertions and deletions in BRCA1 and BRCA2 //Nat. Biotechnol. – 2000.
– V. 18(5). – P. 561–564.160.Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O.,Parmigiani G.,Ochs M.F. A Markov chain Monte Carlo technique for identificationof combinations of allelic variants underlying complex diseases in humans //Genetics.- 2005.- V.171(4). – P.
2113-2121.161.Fekete A., Vér A., Bögi K., Treszl A., Rigó J.Jr. Is preeclampsia associatedwith higher frequency of HSP70 gene polymorphisms? // Eur. J. Obstet. Gynecol.Reprod. Biol. – 2006. – V. 126(2). – P. 197–200.162.Fernández-Real J.M., Straczkowski M., Vendrell J., Soriguer F., Pérez DelPulgar S., Gallart L., López-Bermejo A., Kowalska I., Manco M., Cardona F.,García-Gil M.M., Mingrone G., Richart C., Ricart W., Zorzano A. Protection frominflammatory disease in insulin resistance: the role of mannan-binding lectin //Diabetologia. – 2006.
– V. 49(10). – P. 2402–2411.377378163.Ferreira T., Marchini J. Modeling interactions with known risk loci-aBayesian model averaging approach // Ann. Hum. Genet. – 2011. – V. 75, № 1. P.1–9.164.Fisher S.J. The placental problem: linking abnormal cytotrophoblastdifferentiation to the maternal symptoms of preeclampsia // Reprod.
Biol.Endocrinol. – 2004. – V. 2. – P. 53.165.Fitzpatrick E., Johnson M.P., Dyer T.D., Forrest S., Elliott K., BlangeroJ., Brennecke S.P., Moses E.K. Genetic association of the activin A receptor gene(ACVR2A) and pre-eclampsia // Mol. Hum. Reprod. – 2009. V.15, № 3. – P. 195–204.166.Fomicheva E.V., Gukova S.P., Larionova-Vasina V.I., Kovalev Y.R.,Schwartz E.I.
Gene-gene interaction in the RAS system in the predisposition tomyocardial infarction in elder population of St. Petersburg (Russia) // Mol. Genet.Metab. – 2000. – V. 69(1). – P. 76–80.167.Fornage M., Amos C.I., Kardia S., Sing C.F., Turner S.T., Boerwinkle E.Variation in the region of the angiotensin-converting enzyme gene influencesinterindividual differences in blood pressure levels in young white males //Circulation. – 1998. – V. 12;97(18). – P.
1773–1779.168.Fotin A., Drobyshev A., Proudnikov D., Perov A., Mirzabekov A. Parallelthermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips //Nucleic Acids Res. – 1998. – V. 26. – P. 1515–1521.169.Fox C.S., Heard-Costa N.L., Vasan R.S., Murabito J.M., D'Agostino R.B.Sr., Atwood L.D. Genomewide Linkage Analysis of Weight Change in theFramingham Heart Study // J.
Clin. Endocrinol. Metab. – 2005. – V. 15. – P. 3197–3201.170.Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M.,Roth A., Lin J., Minguez P., Bork P., von Mering C., Jensen L.J. STRING v9.1:protein-protein interaction networks, with increased coverage and integration //Nucleic Acids Res. – 2013. – V. 41.
– P. D808–D815.378379171.Francoual J., Audibert F., Trioche P., Chalas J., Capel L., Lindenbaum A.,Labrune P., Frydman R. Is a polymorphism of the apolipoprotein E geneassociated with preeclampsia? // Hypertens. Pregnancy. – 2002. V. 21, № 2. P.127–133.172.Franke L., van Bakel H., Fokkens L., de Jong E.D., Egmont-Petersen M.,Wijmenga C. Reconstruction of a functional human gene network, with anapplication for prioritizing positional candidate genes // Am. J.
Hum. Genet. –2006. – V. 78, № 6. – P. 1011–1025.173.Freedman J.E., Vitseva O., Tanriverdi K.The role of the bloodtranscriptome in innate inflammation and stroke // Ann. N. Y. Acad. Sci. – 2010. –V. 1207. – P. 41-45.174.Friedländer M.R., Mackowiak S.D., Li N., Chen W., Rajewsky N.miRDeep2 accurately identifies known and hundreds of novel microRNA genes inseven animal clades // Nucleic Acids Res. – 2012. – V. 40(1).
– P. 37–52.175.Frossard P.M., Gonzalez P.A., Fritz L.C., Ponte P.A., Fiddes J.C., AtlasS.A. Two RFLPs at the human renin (ren) gene locus // Nucleic. Acids. Res. –1986. – V. 27;14(10). – P. 4380.176.Frossard P.M., Lestringant G.G., Elshahat Y.I., John A., Obineche E.N. AnMboI two-allele polymorphism may implicate the human renin gene in primaryhypertension // Hypertens.
Res. – 1998. – V. 21(3). – P. 221–225.177.Frossard P.M., Lestringant G.G., Malloy M.J., Kane J.P. Human reningene BglI dimorphism associated with hypertension in two independentpopulations // Clin. Genet. – 1999. – V. 56(6). – P. 428–433.178.Fu G., Brkić J., Hayder H., Peng C. MicroRNAs in Human PlacentalDevelopment and Pregnancy Complications // Int. J.
Mol. Sci. – 2013. – V. 14(3).– P. 5519–5544.179.Fu Y., Katsuya T., Asai T., Fukuda M., Inamoto N., Iwashima Y.,Sugimoto K., Rakugi H., Higaki J., Ogihara T. Lack of correlation between Mbo Irestriction fragment length polymorphism of renin gene and essential hypertensionin Japanese // Hypertens. Res. – 2001. – V. 24(3). – P. 295–298.379380180.Fu G., Brkić J., Hayder H., Peng C. MicroRNAs in Human PlacentalDevelopment and Pregnancy Complications // Int. J. Mol. Sci. – 2013. – V.
14, №3. – P. 5519–5544.181.Gao W.L., Li D., Xiao Z.X., Liao Q.P., Yang H.X., Li Y.X., Ji L., WangY.L. Detection of global DNA methylation and paternally imprinted h19 genemethylation in preeclamptic placentas // Hypertens. Res. – 2011. – V. 34. – P. 655–661.182.Gao W.L., Liu M., Yang Y., Yang H., Liao Q., Bai Y., Li Y.X., Li D.,Peng C., Wang Y.L. // RNA Biol. – 2012. – V. 9, № 7.
– P. 1002–1010.183.Garrison E., Marth G. Haplotype-based variant detection from short-readsequencing // URL:http://arxiv.org/abs/1207.3907.184.Gaunt T.R., Lowe G.D., Lawlor D.A., Casas J.P., Day I.N. A gene-centricanalysis of activated partial thromboplastin time and activated protein C resistanceusing the HumanCVD focused genotyping array // Eur. J. Hum. Genet. – 2013. –V.
21(7). P. –779–783.185.Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N.,Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., GorenY., Chajut A. Serum microRNAs are promising novel biomarkers // PLoS One. –2008. – V. 3. – P. e3148.186.Gloria-Bottini F., Lucarelli P., Antonacci E., Saccucci P., De Lorenzo A.,Bottini E. Genetic polymorphism within human growth hormone gene region andBMI in type 2 diabetes // Acta Diabetol.
– 2006. – V. 43(4). – P. 99–102.187.Glotov A.S., Kazakov S.V., Zhukova E.A., Alexandrov A.V., Glotov O.S.,Pakin V.S., Danilova M.M., Tarkovskaya I.V., Niyazova S.S., Chakova N.N.,Komissarova S.M., Kurnikova E.A., Sarana A.M., Sherbak S.G., SergushichevA.A., Shalyto A.A., Baranov V.S. Targeted next-generation sequencing (NGS) ofnine candidate genes with custom AmpliSeq in patients and a cardiomyopathy riskgroup // Clinica Chimica Acta. – 2015. – V.
15, № 446. – С. 132–140.188.Glotov A.S., Tiys E.S., Vashukova E.S., Pakin V.S., Demenkov P.S., SaikO.V., Ivanisenko T.V., Arzhanova O.V., Mozgovaya E.V., Zainulina M.S.,380381Kolchanov N.A., Baranov V.S., Ivanisenko V.A. Associative networks of potentialmolecular and genetic contributors in combined preeclampsia (preeclampsiaassociome) // BMC Systems biology.
– 2015. – V. 9, S. 4. – P. 2–12.189.Glotov A.S., Sinitsyna E.S., Danilova M.M., Vashukova E.S., Walter J.G.,Stahl F., Baranov V.S., Vlakh E.G., Tennikova T.B. Detection of human genomemutations associated with pregnancy complications using 3-D microarray based onmacroporous polymer monoliths // Talanta. – 2016. – V. 147.
P. 537–546.190.Godbole G., Suman P., Gupta S.K., Modi D. Decidualized endometrialstromal cell derived factors promote trophoblast invasion // Fertil. Steril. – 2011. –V. 95. – P.1278–1283.191.Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabási A.L. Thehuman disease network // Proc. Natl.
Acad. Sci. USA. – 2007. – V. 104, № 21. – P.8685–8690.192.Golan D., Lander E.S., Rosset S. Measuring missing heritability: inferringthe contribution of common variants // Proc. Natl. Acad. Sci. U S A.- 2014. – V.111(49). – P .5272-5281.193.Goldberg D.S., Roth F.P. Assessing experimentally derived interactions ina small world // Proc. Natl. Acad.
Sci. U S A. – 2003. – V. 100, № 8. – P. 4372–4376.194.Goncalves A., Tikhonov A., Brazma A., Kapushesky M. A pipeline forRNA-seq data processing and quality assessment // Bioinformatics. – 2011. – V.27, № 6. – P. 867–869.195.Gorshkova E.S., Minushkina L.O., Brovkin A.N., Brazhnik V.A., NosikovV.V., Zateĭshchikov D.A. Genetic predisposition to development of atrialfibrillation in patients with hypertensive disease // Kardiologiia. – 2010.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
